ASML On The Verge Of Losing EUV Monopoly
ASML faces a 40% stock decline, slowing growth, and rising Chinese competition. Read here for an analysis key risks and why ...
The Financial Express39m
LIVE: Trump tariffs trigger sell-off; Nifty near 23,300, Sensex down 200 points, pharma stocks rally
Indian equity markets slipped during Thursday's trade after Trump announced 26% tariffs on foreign imports to the US.